A registered study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- OBSERVATIONAL
- Evidence population
- Human clinical study registration
- Participants
- 205
- Population
- ALL · 60 Years
- Duration
- 2020-07-03 to 2024-10-17
- Intervention
- Comprehensive geriatric assessment (CGA)
- Comparator
- Not reported
- Outcomes measured
- Overall survival — at one year post allogeneic hematopoietic stem cell transplantation; Overall survival — at two years post allogeneic hematopoietic stem cell transplantation; Morbidity Index — at one year; Morbidity Index — at two years; Survival without disease and chronic graft-versus-host disease — at one year post allogeneic hematopoietic stem cell tr…; Survival without disease and chronic graft-versus-host disease — at two years post allogeneic hematopoietic stem cell t…; Proportion of patient with Viral Reactivation — at one year; Acute graft-versus-host disease — at 100 days; Chronic graft-versus-host disease — at 1 year; Chronic graft-versus-host disease — at 2 years; Incidence of relapse — at two years; Walk test — at day 100; Walk test — at one year; Walk test — at two years; Nutritional score — at day 100; Nutritional score — at one year; Nutritional score — at two years; Karnofsky index — at day 100; Karnofsky index — at one year; Evaluation of autonomy — at one year
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Stem cells · 100%Title contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.
Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.